DJ-1 in Dopaminergic Neuronal Function and Survival
DJ-1 在多巴胺能神经元功能和存活中的作用
基本信息
- 批准号:6963776
- 负责人:
- 金额:$ 36.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:Parkinson&aposs diseasebehavior testdopamineelectrophysiologygene expressiongene mutationgene targetinggenetically modified animalshigh performance liquid chromatographylaboratory mousemicrodialysisneural degenerationneural transmissionneurogeneticsneurophysiologyoxidationparkin gene /proteinphenotypepsychomotor functionsubstantia nigra
项目摘要
Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by resting tremor, rigidity and bradykinesia. These clinical features are thought to arise from reduced dopaminergic input to the striatum, which is caused by the degeneration of dopaminergic neurons in the substantia nigra. The occurrence of PD is largely sporadic, but clinical syndromes resembling sporadic PD can also be caused by mutations in the alpha-synuclein, parkin, DJ-I and PINK1 genes. Elucidation of the pathogenic mechanisms underlying the selective dopaminergic degeneration in familial parkinsonism will likely provide important clues to the pathogenic mechanisms responsible for idiopathic PD. The recessive inheritance mode of the mutations and the existence of large exonic deletions in the, parkin, DJ-1 and PINK1 genes indicate that loss of function of a single gene product can lead to clinical manifestations of parkinsonism and selective dopaminergic degeneration. We take advantage of the identification of these genes to study the mechanisms by which loss-of-function mutations in these genes result in manifestations of parkinsonian features through the generation of mutant mice. Our previous generation and analysis of parkin-/- mice have shown nigrostriatal deficits and mitochondrial dysfunction in the absence of loss of dopaminergic neurons, suggesting that these functional deficits likely precede neurodegeneration, and that mitochondrial dysfunction may be causal in PD pathogenesis. In this proposal, we hypothesize that loss-of function mutations in the DJ-1 gene alter the normal physiology of dopaminergic neurons in the substantia nigra, ultimately leading to their degeneration and production of parkinsonian phenotypes. To test this hypothesis, we propose the following three Specific Aims. First, we will generate and analyze DJ-1-/-null mice for disruption of normal dopaminergic neurotransmission, loss of dopaminergic neurons and motor impairments. Second, we will determine whether loss of DJ-1 function results in mitochondrial dysfunction and increased oxidative damage. Third, since mouse models bearing mutations in a single pathogenic gene, such as parkin-null mice and alpha-synuclein transgenic mice, fail to develop the cardinal feature of PD, namely selective dopaminergic degeneration, we will investigate whether the presence of two pathogenic mutations accelerates the dysfunction and degeneration of dopaminergic neurons in mice deficient in both DJ-1 and parkin. Our long-term goal is to develop a genetic mouse model that recapitulates all central features of PD and to characterize the molecular pathways responsible for PD pathogenesis.
帕金森氏病(PD)是一种与年龄相关的神经退行性疾病,其特征是静止震颤,僵硬和头霉素。这些临床特征被认为是纹状体的多巴胺能输入降低引起的,纹状体是由黑质中多巴胺能神经元变性引起的。 PD的发生在很大程度上是零星的,但是类似于零星PD的临床综合征也可能是由α-突触核蛋白,Parkin,DJ-I和Pink1基因突变引起的。阐明家族性帕金森氏症选择性多巴胺能变性背后的致病机制可能会为导致特发性PD的致病机制提供重要的线索。突变的隐性遗传模式以及帕金,DJ-1和Pink1基因中大型外显子缺失的存在表明,单个基因产物的功能丧失可以导致帕金森主义和选择性多巴胺能退化的临床表现。我们利用这些基因的鉴定来研究这些基因中功能丧失突变的机制,从而通过产生突变小鼠导致帕金森氏症特征的表现。我们对帕克蛋白 - / - 小鼠的上一代和分析表明,在没有多巴胺能神经元丧失的情况下,骨纹状体缺陷和线粒体功能障碍,这表明这些功能性缺陷可能是神经退行性的之前的,而线粒体功能障碍可能是PD PDDEDENEGONENEN中的神经性功能障碍。在此提案中,我们假设DJ-1基因中的功能丧失突变改变了尼格拉省多巴胺能神经元的正常生理学,最终导致了它们的退化和产生帕金森氏症表型。为了检验这一假设,我们提出以下三个特定目标。首先,我们将生成和分析DJ-1 - / - 无效小鼠,以破坏正常的多巴胺能神经传递,多巴胺能神经元和运动障碍的丧失。其次,我们将确定DJ-1功能的丧失是否导致线粒体功能障碍并增加氧化损伤。 Third, since mouse models bearing mutations in a single pathogenic gene, such as parkin-null mice and alpha-synuclein transgenic mice, fail to develop the cardinal feature of PD, namely selective dopaminergic degeneration, we will investigate whether the presence of two pathogenic mutations accelerates the dysfunction and degeneration of dopaminergic neurons in mice deficient in both DJ-1 and帕金。我们的长期目标是开发一种遗传小鼠模型,该模型概括了PD的所有主要特征,并表征了负责PD发病机理的分子途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jie Shen其他文献
Jie Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jie Shen', 18)}}的其他基金
Evaluation of Oral Modified-Release Tablets to Support the Approval of Additional Strengths
评估口服缓释片以支持其他规格的批准
- 批准号:
10937015 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
In Vitro Based Approaches to Evaluate the Bioequivalence of Locally-Acting Rectal and Vaginal Semi-Solid Drug Products
评估局部作用直肠和阴道半固体药品生物等效性的体外方法
- 批准号:
10599677 - 财政年份:2022
- 资助金额:
$ 36.8万 - 项目类别:
In Vitro Based Approaches to Evaluate the Bioequivalence of Locally-Acting Rectal and Vaginal Semi-Solid Drug Products
评估局部作用直肠和阴道半固体药品生物等效性的体外方法
- 批准号:
10937020 - 财政年份:2022
- 资助金额:
$ 36.8万 - 项目类别:
BIOEQUIVALENCE CONSIDERATIONS OF TOPICAL RECTAL AND VAGINAL SUPPOSITORIES
外用直肠和阴道栓剂的生物等效性考虑因素
- 批准号:
10006319 - 财政年份:2019
- 资助金额:
$ 36.8万 - 项目类别:
Epigenetic Regulation of Bone Regeneration in Inflammatory Disease
炎症性疾病中骨再生的表观遗传调控
- 批准号:
9974476 - 财政年份:2019
- 资助金额:
$ 36.8万 - 项目类别:
Epigenetic Regulation of Bone Regeneration in Inflammatory Disease
炎症性疾病中骨再生的表观遗传调控
- 批准号:
10433827 - 财政年份:2019
- 资助金额:
$ 36.8万 - 项目类别:
Epigenetic Regulation of Bone Regeneration in Inflammatory Disease
炎症性疾病中骨再生的表观遗传调控
- 批准号:
10192663 - 财政年份:2019
- 资助金额:
$ 36.8万 - 项目类别:
BIOEQUIVALENCE CONSIDERATIONS OF TOPICAL RECTAL AND VAGINAL SUPPOSITORIES
外用直肠和阴道栓剂的生物等效性考虑因素
- 批准号:
9914054 - 财政年份:2019
- 资助金额:
$ 36.8万 - 项目类别:
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
α-突触核蛋白和 LRRK2 在帕金森病发病机制中的作用
- 批准号:
10268520 - 财政年份:2015
- 资助金额:
$ 36.8万 - 项目类别:
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
α-突触核蛋白和 LRRK2 在帕金森病发病机制中的作用
- 批准号:
9297399 - 财政年份:2015
- 资助金额:
$ 36.8万 - 项目类别:
相似国自然基金
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
间质性肺疾病致肺气体交换功能改变的超极化129Xe MRI定量研究
- 批准号:82372150
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
缺血性脑卒中疾病中NLRP6磷酸化修饰的鉴定及其在调控炎性小体活化中的作用和机制研究
- 批准号:82302474
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
小胶质细胞清除后骨髓移植延缓csf1r点突变小鼠疾病进展的机制研究
- 批准号:82301526
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
数据驱动的心血管疾病区域协同医疗服务研究
- 批准号:72301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
The effect of aging on neurotransmitters and motor performance in a primate model
衰老对灵长类动物模型中神经递质和运动表现的影响
- 批准号:
10573386 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Lysosomal control of plasma membrane -endoplasmic reticulum membrane contacts regulates neuronal excitability
溶酶体控制质膜-内质网膜接触调节神经元兴奋性
- 批准号:
10622184 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
PME-1: Pathogenetic Role and Therapeutic Opportunity in Neurodegenerative Mixed Proteinopathies
PME-1:神经退行性混合蛋白病的致病作用和治疗机会
- 批准号:
10595891 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别: